Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AQST · as of Mar 31, 2025
Ownership Breakdown
125
Institutional Holders
▲ 7 vs Q4
$130.79M
Total Inst. Value
▼ $23.64M vs Q4
99.31M
Shares Outstanding
freeFloat 96.04%
44.25M
13F Shares Held
▲ 873,377 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AQST largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BRATTON CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 9.81M | 10.27% | 10.27% | $28.45B | May 15, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 5.94M | 6.22% | 6.22% | $17.21B | May 2, 2025 | ▼ 62.8K |
VANGUARD GROUP INC pharmaceutical preparations | 4.07M | 4.27% | 4.27% | $11.81B | May 9, 2025 | ▼ 273.2K |
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 3.73M | 3.90% | 3.90% | $10.81B | Aug 6, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.70M | 1.78% | 1.78% | $4.93B | May 13, 2025 | ▲ 46.1K |
MORGAN STANLEY pharmaceutical preparations | 1.53M | 1.60% | 1.60% | $4.43B | May 15, 2025 | ▲ 790.4K |
STATE STREET CORP pharmaceutical preparations | 1.52M | 1.59% | 1.59% | $4.42B | May 15, 2025 | ▲ 18.8K |
PALE FIRE CAPITAL SE pharmaceutical preparations | 1.34M | 1.40% | 1.40% | $3.87B | May 14, 2025 | ▲ 809.9K |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 1.33M | 1.39% | 1.39% | $3.86B | May 15, 2025 | ▲ 640.2K |
JANNEY MONTGOMERY SCOTT LLC pharmaceutical preparations | 1.06M | 1.11% | 1.11% | $3.07B | Apr 17, 2025 | ▲ 75.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
31
Increased
+4.74M shares6
New Positions
first time holders10
Decreased
−578.2K shares0
Sold Out
fully exitedNet shares change (top 50)
+4.17M
+4.74M / −578.2K
Net new holders
+27
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AQST insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
8
Sell transactions
0.25
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Zalewski Thomas A. Chief Legal Officer | May 18, 2026 | Award | 100,000 | — | — | 100.0K | Form 4 ↗ |
Zalewski Thomas A. Chief Legal Officer | May 18, 2026 | Award | 75,000 | $4.13 | $310.1K | 75.0K | Form 4 ↗ |
Barber Daniel President and CEO | May 15, 2026 | Sale | 8,257 | $4.29 | $35.4K | 660.6K | Form 4 ↗ |
Cioffi Melina SVP, Regulatory Affairs | May 15, 2026 | Tax Withhold | 1,667 | $4.17 | $7.0K | 273.2K | Form 4 ↗ |
BRAENDER LORI J Corporate Secretary | May 7, 2026 | Tax Withhold | 135,690 | $4.23 | $574.0K | 231.0K | Form 4 ↗ |
Boyd Peter E. Chief People Officer | May 5, 2026 | Tax Withhold | 56,778 | $4.18 | $237.3K | 281.7K | Form 4 ↗ |
Barber Daniel President and CEO | May 5, 2026 | Tax Withhold | 335,922 | $4.18 | $1.40M | 668.8K | Form 4 ↗ |
TOTH A ERNEST JR Chief Financial Officer | May 5, 2026 | Tax Withhold | 92,652 | $4.18 | $387.3K | 283.5K | Form 4 ↗ |
Jung Cassie Chief Operating Officer | May 5, 2026 | Tax Withhold | 72,734 | $4.18 | $304.0K | 202.2K | Form 4 ↗ |
BRAENDER LORI J Corporate Secretary | May 5, 2026 | Tax Withhold | 76,147 | $4.18 | $318.3K | 366.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Aquestive Therapeutics, Inc. (AQST) is primarily owned by institutional investors, who hold approximately 44.6% of total shares outstanding. Company insiders own approximately 3.96%, while retail and public investors account for the remaining 51.48%.
The largest institutional shareholder of Aquestive Therapeutics, Inc. is BRATTON CAPITAL MANAGEMENT, L.P., holding approximately 9.81 million shares — equal to 10.27% of outstanding shares — as of March 31, 2025.
A total of 125 institutional investors currently hold AQST stock, with a combined institutional value of approximately $130,791,100 as of the most recent 13F filing period.
Frequently asked questions
AQST ownershipAquestive Therapeutics, Inc. (AQST) is primarily owned by institutional investors, who hold approximately 44.6% of shares. The largest shareholder is BRATTON CAPITAL MANAGEMENT, L.P. with a 10.27% stake. Company insiders hold 3.96%. Data sourced from SEC Form 13F as of March 31, 2025.